{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:34:34Z","timestamp":1793136874954,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ogc.2017.11.001","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T03:25:42Z","timestamp":1518060342000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell-Free DNA"],"prefix":"10.1016","volume":"45","author":[{"given":"Kristin D.","family":"Gerson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinchem\/48.3.421","article-title":"Predominant hematopoietic origin of cell-free dna in plasma and serum after sex-mismatched bone marrow transplantation","volume":"48","author":"Lui","year":"2002","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/pd.1700","article-title":"Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast","volume":"27","author":"Alberry","year":"2007","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","article-title":"Size distributions of maternal and fetal DNA in maternal plasma","volume":"50","author":"Chan","year":"2004","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.ogc.2017.11.001_bib4","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1373\/clinchem.2010.144188","article-title":"Analysis of the size distributions of fetal and maternal cell-free DNA by paired-end sequencing","volume":"56","author":"Fan","year":"2010","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13\u00a0weeks\u2019 gestation: relation to maternal and fetal characteristics","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib6","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Cell- free DNA screening for fetal aneuploidy","volume":"126","author":"ACOG","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1086\/302205","article-title":"Rapid clearance of fetal DNA from maternal plasma","volume":"64","author":"Lo","year":"1999","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib8","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1073\/pnas.76.3.1453","article-title":"Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting","volume":"76","author":"Herzenberg","year":"1979","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8676","key":"10.1016\/j.ogc.2017.11.001_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(89)91969-7","article-title":"Prenatal sex determination by DNA amplification from maternal peripheral blood","volume":"2","author":"Lo","year":"1989","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ogc.2017.11.001_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/pd.1970141308","article-title":"Isolating fetal cells in maternal circulation for prenatal diagnosis","volume":"14","author":"Simpson","year":"1994","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.ogc.2017.11.001_bib11","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1182\/blood.V88.11.4390.bloodjournal88114390","article-title":"Two-way cell traffic between mother and fetus: biologic and clinical implications","volume":"88","author":"Lo","year":"1996","journal-title":"Blood"},{"issue":"9076","key":"10.1016\/j.ogc.2017.11.001_bib12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib13","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1373\/clinchem.2008.111385","article-title":"Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma","volume":"54","author":"Lun","year":"2008","journal-title":"Clin Chem"},{"issue":"42","key":"10.1016\/j.ogc.2017.11.001_bib14","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","article-title":"Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood","volume":"105","author":"Fan","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"51","key":"10.1016\/j.ogc.2017.11.001_bib15","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","article-title":"Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma","volume":"105","author":"Chiu","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ogc.2017.11.001_bib16","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.12688\/f1000research.9215.1","article-title":"Recent advances in prenatal genetic screening and testing","volume":"5","author":"Van den Veyver","year":"2016","journal-title":"F1000Res"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pd.2730","article-title":"Aneuploidy screening: a position statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, January 2011","volume":"31","author":"Benn","year":"2011","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/uog.17484","article-title":"Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis","volume":"50","author":"Gil","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ogc.2017.11.001_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1177\/1933719115584445","article-title":"Effects of maternal and fetal characteristics on cell-free fetal DNA fraction in maternal plasma","volume":"22","author":"Zhou","year":"2015","journal-title":"Reprod Sci"},{"issue":"11","key":"10.1016\/j.ogc.2017.11.001_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/pd.4668","article-title":"The influence of low molecular weight heparin medication on plasma DNA in pregnant women","volume":"35","author":"Gr\u00f6mminger","year":"2015","journal-title":"Prenat Diagn"},{"issue":"17","key":"10.1016\/j.ogc.2017.11.001_bib21","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2017.11.001_bib22","first-page":"413.e1-9","article-title":"Obesity and cell-free DNA \u201cno calls\u201d: is there an optimal gestational age at time of sampling?","volume":"216","author":"Livergood","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2017.11.001_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"issue":"4","key":"10.1016\/j.ogc.2017.11.001_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000346806","article-title":"Maternal plasma cell-free fetal and maternal DNA at 11-13\u00a0weeks\u2019 gestation: relation to fetal and maternal characteristics and pregnancy outcomes","volume":"33","author":"Poon","year":"2013","journal-title":"Fetal Diagn Ther"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib25","doi-asserted-by":"crossref","first-page":"727.e1-6","DOI":"10.1016\/j.ajog.2015.12.018","article-title":"Cell-free DNA vs sequential screening for the detection of fetal chromosomal abnormalities","volume":"214","author":"Norton","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib26","doi-asserted-by":"crossref","first-page":"79e1-9","DOI":"10.1016\/j.ajog.2014.10.012","article-title":"Detection of triploid, molar, and vanishing twin pregnancies by a single-nucleotide polymorphism-based noninvasive prenatal test","volume":"212","author":"Curnow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ogc.2017.11.001_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/pd.4100","article-title":"Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease","volume":"33","author":"Osborne","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/gim.2016.113","article-title":"Accuracy and clinical value of maternal incidental findings during noninvasive prenatal testing for fetal aneuploidies","volume":"19","author":"Brison","year":"2017","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.ogc.2017.11.001_bib31","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajog.2014.12.033","article-title":"Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values","volume":"212","author":"Wax","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/pd.4666","article-title":"Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective","volume":"35","author":"Sachs","year":"2015","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.ogc.2017.11.001_bib33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/jama.2016.11139","article-title":"Modeled fetal risk of genetic diseases identified by expanded carrier screening","volume":"316","author":"Haque","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2017.11.001_bib34","series-title":"Biomedical sciences essential laboratory medicine","author":"Docherty","year":"2012"},{"issue":"4","key":"10.1016\/j.ogc.2017.11.001_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1439-0272.2003.00579.x","article-title":"Are children of older fathers at risk for genetic disorders?","volume":"35","author":"Jung","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.ogc.2017.11.001_bib36","first-page":"745","article-title":"Genetic disease in the offspring of older fathers","volume":"57","author":"Friedman","year":"1981","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/GIM.0b013e318176fabb","article-title":"Statement on guidance for genetic counseling in advanced paternal age","volume":"10","author":"Toriello","year":"2008","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajmg.1320130114","article-title":"The effect of parental age on rate of mutation for Duchenne Muscular dystrophy","volume":"13","author":"Yasuda","year":"1982","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ogc.2017.11.001_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2516.1997.00089.x","article-title":"Analysis of the haemophilia A mutation in sporadic patients registered at the Royal London Hospital and their families","volume":"3","author":"Tagliavacca","year":"1997","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib40","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/AOG.0000000000001405","article-title":"Practice bulletin no. 162: prenatal diagnostic testing for genetic disorders","volume":"127","author":"Jackson","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/humupd\/dmn047","article-title":"The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis","volume":"15","author":"Wright","year":"2009","journal-title":"Hum Reprod Update"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/pd.4123","article-title":"Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples","volume":"33","author":"Futch","year":"2013","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib43","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/gim.2014.92","article-title":"Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases","volume":"17","author":"Wang","year":"2015","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.ogc.2017.11.001_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/pd.4832","article-title":"Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways","volume":"36","author":"Verhoef","year":"2016","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ogc.2017.11.001_bib45","article-title":"Nonivasive prenatal diagnosis of single-gene disorders using droplet digital PCR","author":"Camunas-Soler","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ogc.2017.11.001_bib46","series-title":"Fetal and neonatal brain injury: mechanisms, management and the risks of practice","author":"Stevenson","year":"2009"},{"issue":"2","key":"10.1016\/j.ogc.2017.11.001_bib47","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/GIM.0b013e3181971ccb","article-title":"Guidelines for the prenatal diagnosis of fetal skeletal dysplasias","volume":"11","author":"Krakow","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.ogc.2017.11.001_bib48","series-title":"Genetic disorders and the fetus: diagnosis, prevention, and treatment","author":"Milunsky","year":"2015"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1373\/clinchem.2016.266544","article-title":"Emerging considerations for noninvasive prenatal testing","volume":"63","author":"Korpi-Steiner","year":"2017","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/pd.4585","article-title":"Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis","volume":"35","author":"Hill","year":"2015","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib51","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s10897-014-9725-4","article-title":"Client views and attitudes to non-invasive prenatal diagnosis for sickle cell disease, thalassaemia and cystic fibrosis","volume":"23","author":"Hill","year":"2014","journal-title":"J\u00a0Genet Couns"},{"issue":"4","key":"10.1016\/j.ogc.2017.11.001_bib52","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cge.12179","article-title":"Non-invasive prenatal diagnosis for single gene disorders: experience of patients","volume":"85","author":"Lewis","year":"2014","journal-title":"Clin Genet"},{"issue":"8","key":"10.1016\/j.ogc.2017.11.001_bib53","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ejhg.2014.238","article-title":"An easy test but a hard decision: ethical issues concerning non-invasive prenatal testing for autosomal recessive disorders","volume":"23","author":"Skirton","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ogc.2017.11.001_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.midw.2015.12.009","article-title":"Impact of fetal or child loss on parents\u2019 perceptions of non-invasive prenatal diagnosis for autosomal recessive conditions","volume":"34","author":"Pisnoli","year":"2016","journal-title":"Midwifery"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/bioe.12125","article-title":"For your interest? The ethical acceptability of using non-invasive prenatal testing to test \u201cpurely for information\u201d","volume":"29","author":"Deans","year":"2015","journal-title":"Bioethics"},{"issue":"7","key":"10.1016\/j.ogc.2017.11.001_bib56","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/pd.4583","article-title":"Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach","volume":"35","author":"Chitty","year":"2015","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.ogc.2017.11.001_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/clinchem\/46.2.301","article-title":"Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma","volume":"46","author":"Amicucci","year":"2000","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib58","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pd.570","article-title":"Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR","volume":"23","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2003","journal-title":"Prenat Diagn"},{"issue":"13","key":"10.1016\/j.ogc.2017.11.001_bib59","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/pd.2385","article-title":"Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma","volume":"29","author":"Meaney","year":"2009","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ogc.2017.11.001_bib60","unstructured":"Available at: https:\/\/www.natera.com\/vistara. Accessed November 06, 2017."},{"key":"10.1016\/j.ogc.2017.11.001_bib61","unstructured":"Available at: http:\/\/www.ravgen.com\/single-gene-disorder-testing\/. Accessed November 06, 2017."},{"key":"10.1016\/j.ogc.2017.11.001_bib62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-319-42044-8_14","article-title":"Implementing non-invasive prenatal diagnosis (Nipd) in a national health service laboratory; From dominant to recessive disorders","volume":"924","author":"Drury","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib63","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/clinchem\/48.5.778","article-title":"Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study","volume":"48","author":"Chiu","year":"2002","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib64","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/pd.439","article-title":"Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma","volume":"22","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2002","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-med-091014-115715","article-title":"Prenatal diagnosis innovation: genome sequencing of maternal plasma","volume":"67","author":"Wong","year":"2016","journal-title":"Annu Rev Med"},{"issue":"50","key":"10.1016\/j.ogc.2017.11.001_bib66","doi-asserted-by":"crossref","first-page":"19920","DOI":"10.1073\/pnas.0810373105","article-title":"Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma","volume":"105","author":"Lun","year":"2008","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib67","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1373\/clinchem.2011.178939","article-title":"Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia","volume":"58","author":"Barrett","year":"2012","journal-title":"Clin Chem"},{"issue":"13","key":"10.1016\/j.ogc.2017.11.001_bib68","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2010-10-310789","article-title":"Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA","volume":"117","author":"Tsui","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ogc.2017.11.001_bib69","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1373\/clinchem.2016.268375","article-title":"Universal haplotype-based noninvasive prenatal testing for single gene diseases","volume":"63","author":"Hui","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ogc.2017.11.001_bib70","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bpobgyn.2016.10.016","article-title":"Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA","volume":"39","author":"Hudecova","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ogc.2017.11.001_bib71","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GCO.0000000000000347","article-title":"Noninvasive prenatal diagnosis for single gene disorders","volume":"29","author":"Allen","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib72","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/uog.15947","article-title":"Targeted sequencing of maternal plasma for haplotype-based non-invasive prenatal testing of spinal muscular atrophy","volume":"49","author":"Chen","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib73","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1172\/JCI79322","article-title":"Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations","volume":"125","author":"Zeevi","year":"2015","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib74","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1373\/clinchem.2014.229328","article-title":"Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART)","volume":"61","author":"Lv","year":"2015","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ogc.2017.11.001_bib75","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/GCO.0000000000000252","article-title":"Noninvasive prenatal testing beyond genomic analysis: what the future holds","volume":"28","author":"Hui","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib76","doi-asserted-by":"crossref","first-page":"F62","DOI":"10.1136\/fn.78.1.F62","article-title":"Consequences for fetus and neonate of maternal red cell allo-immunisation","volume":"78","author":"Howard","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"8","key":"10.1016\/j.ogc.2017.11.001_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden","volume":"87","author":"Gottvall","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"10.1016\/j.ogc.2017.11.001_bib78","doi-asserted-by":"crossref","first-page":"e70984","DOI":"10.1371\/journal.pone.0070984","article-title":"Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--Outcome of a new antenatal screening and prevention program","volume":"8","author":"Tiblad","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ogc.2017.11.001_bib79","article-title":"Anti-D administration in pregnancy for preventing Rhesus alloimmunisation","author":"McBain","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"8853","key":"10.1016\/j.ogc.2017.11.001_bib80","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0140-6736(93)93161-S","article-title":"Prenatal determination of fetal RhD status by analysis of peripheral blood of rhesus negative mothers","volume":"341","author":"Lo","year":"1993","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ogc.2017.11.001_bib81","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199812103392402","article-title":"Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma","volume":"339","author":"Lo","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.ogc.2017.11.001_bib82","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3109\/14767058.2014.882306","article-title":"Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis","volume":"27","author":"Zhu","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"10","key":"10.1016\/j.ogc.2017.11.001_bib83","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.4419","article-title":"Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2years of screening experience from Denmark","volume":"34","author":"Clausen","year":"2014","journal-title":"Prenat Diagn"},{"issue":"11","key":"10.1016\/j.ogc.2017.11.001_bib84","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/j.1471-0528.2011.03028.x","article-title":"Noninvasive fetal blood group genotyping of rhesus D, c, e and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience","volume":"118","author":"Scheffer","year":"2011","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib85","doi-asserted-by":"crossref","first-page":"606.e1-5","DOI":"10.1016\/j.ajog.2016.06.054","article-title":"Diagnostic accuracy of fetal rhesus D genotyping using cell-free fetal DNA during the first trimester of pregnancy","volume":"215","author":"Vivanti","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib86","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib87","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jogc.2016.12.006","article-title":"No. 343-routine non-invasive prenatal prediction of fetal RHD genotype in Canada: the time is here","volume":"39","author":"Johnson","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"1","key":"10.1016\/j.ogc.2017.11.001_bib88","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-2393-14-87","article-title":"Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHDgenotyping and a review of policy and practice","volume":"14","author":"Kent","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"12","key":"10.1016\/j.ogc.2017.11.001_bib89","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/1471-0528.13055","article-title":"Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS","volume":"122","author":"Soothill","year":"2015","journal-title":"BJOG"},{"issue":"2, Part 1","key":"10.1016\/j.ogc.2017.11.001_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/AOG.0b013e31825d33d9","article-title":"Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy","volume":"120","author":"Wikman","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2017.11.001_bib91","doi-asserted-by":"crossref","first-page":"g5243","DOI":"10.1136\/bmj.g5243","article-title":"Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study","volume":"349","author":"Chitty","year":"2014","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ogc.2017.11.001_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AOG.0000000000001741","article-title":"Circulating cell-free DNA to determine the fetal RHD status in all three trimesters of pregnancy","volume":"128","author":"Moise","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ogc.2017.11.001_bib93","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.AOG.0000260957.77090.4e","article-title":"Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy","volume":"109","author":"van Wamelen","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ogc.2017.11.001_bib94","first-page":"600","article-title":"Management of rhesus alloimmunization in pregnancy","volume":"100","author":"Moise","year":"2002","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854517301602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854517301602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T22:02:11Z","timestamp":1603836131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854517301602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0889854517301602"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2017.11.001","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-Free DNA","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2017.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}